Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease
- PMID: 14617549
- PMCID: PMC1767979
- DOI: 10.1136/heart.89.12.1411
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease
Abstract
Background: Thrombogenesis, angiogenesis, and endothelial damage/dysfunction are components in the pathogenesis of atherosclerosis.
Objective: To investigate the relation of these variables to atherosclerotic disease severity and the possible interrelations between the three.
Methods: 111 patients attending for coronary angiography were studied (85 male, 26 female; mean (SD) age, 61.6 (10.0) years). Plasma concentrations of von Willebrand factor (vWf, a marker of endothelial damage/dysfunction), vascular endothelial growth factor (VEGF, associated with angiogenesis), soluble VEGF receptor Flt-1 (sFlt-1), and tissue factor (TF, a key component of coagulation) were measured by an enzyme linked immunosorbent assay. Following angiography, disease severity was assessed by the number of coronary vessels diseased (> 50% stenosis) and by a coronary atheroma score.
Results: All indices were raised in the patients compared with 34 healthy controls except sFlt-1, which was lower in the patients. No significant correlations were found between the coronary atheroma score and values of vWf (Spearman correlations: r = 0.21, p = 0.83), VEGF (r = 0.11, p = 0.27), or TF (r = -0.04, p = 0.68). However, there was an inverse correlation between plasma sFlt-1 and coronary atheroma score (r = -0.19, p = 0.049). The number of vessels diseased had no relation to any marker. Correlations were found between TF and VEGF (r = 0.25, p = 0.008) and between TF and sFlt-1 (r = 0.42, p < 0.001) in the patients.
Conclusions: Despite evidence of abnormal angiogenesis (VEGF and sFlt-1), thrombogenesis (TF), and endothelial damage/dysfunction (vWf) in the patients with coronary artery disease, there was no correlation between VEGF, sFlt-1, vWf, or TF and angiographically defined disease severity.
Similar articles
-
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma.Br J Ophthalmol. 2002 Nov;86(11):1299-302. doi: 10.1136/bjo.86.11.1299. Br J Ophthalmol. 2002. PMID: 12386093 Free PMC article.
-
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2115-9. Invest Ophthalmol Vis Sci. 2000. PMID: 10892852
-
Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?Clin Sci (Lond). 2003 Apr;104(4):397-404. doi: 10.1042/CS20020182. Clin Sci (Lond). 2003. PMID: 12653684
-
von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.Circulation. 2008 Mar 18;117(11):1449-59. doi: 10.1161/CIRCULATIONAHA.107.722827. Circulation. 2008. PMID: 18347221 Review.
-
Importance of microembolization and inflammation in atherosclerotic heart disease.Am Heart J. 2000 Dec;140(6 Suppl):S90-102. doi: 10.1067/mhj.2000.111611. Am Heart J. 2000. PMID: 11100003 Review.
Cited by
-
Serum VEGF: Diagnostic Value of Acute Coronary Syndrome from Stable Angina Pectoris and Prognostic Value of Coronary Artery Disease.Cardiol Res Pract. 2020 Jan 10;2020:6786302. doi: 10.1155/2020/6786302. eCollection 2020. Cardiol Res Pract. 2020. PMID: 32411449 Free PMC article.
-
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.J Cell Mol Med. 2010 Mar;14(3):528-52. doi: 10.1111/j.1582-4934.2009.00941.x. Epub 2009 Oct 16. J Cell Mol Med. 2010. PMID: 19840194 Free PMC article. Review.
-
Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.Clin Infect Dis. 2009 Oct 1;49(7):1119-27. doi: 10.1086/605578. Clin Infect Dis. 2009. PMID: 19712036 Free PMC article.
-
T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.PLoS One. 2012;7(9):e46073. doi: 10.1371/journal.pone.0046073. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23029393 Free PMC article.
-
Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals.Antivir Ther. 2011;16(4):555-63. doi: 10.3851/IMP1784. Antivir Ther. 2011. PMID: 21685543 Free PMC article.
References
-
- Donati MB, Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 2001;106:18–24. - PubMed
-
- Francis JL. Haemostasis and cancer. Med Lab Sci 1989;46:331–46. - PubMed
-
- Mackman N. Gene targeting in hemostasis. tissue factor. Front Biosci 2001;6:D208–15. - PubMed
-
- Kamat BR, Galli SJ, Barger AC, et al. Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis. Hum Pathol 1987;18:1036–42. - PubMed
-
- Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 2001;3:225–33. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous